A fixed-sequence, open-label study to determine the activity of SCH 717454 (robatumumab) as assessed by positron emission tomography in patients with relapsed or recurrent colorectal cancer.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 3584-3584
◽
2013 ◽
Vol 333
◽
pp. e125-e126
◽
Keyword(s):
2007 ◽
Vol 50
(1)
◽
pp. 102-114
◽
2004 ◽
Vol 39
(1)
◽
pp. 8-12
◽
2000 ◽
Vol 180
(1)
◽
pp. 1-5
◽
1994 ◽
Vol 81
(11)
◽
pp. 1666-1670
◽
2003 ◽
Vol 10
(1)
◽
pp. 59-64
◽
2007 ◽
Vol 68
(11)
◽
pp. 580-583
2001 ◽
Vol 97
(1)
◽
pp. 9-13
◽